Christina Furebring PhD

Christina Furebring is born on 1964. She is Senior Vice President Research and Development since 2001. She is a Swedish graduate engineer and has a doctorate in immune technology from Lund University. She is also a co-founder of the FIND technology which is a cornerstone of Alligator’s technology platform. Christina Furebring has more than 20 years’ experience of working on the optimization of proteins and antibodies. Member of the Management Team since 2001. She is also Deputy Board Member in A Bioscience Incentive AB and Atlas Therapeutics AB.

Dr. Furebring joined Alligator Bioscience in 2001, as a SVP Research she is responsible for the pipeline program consisting of mono and bispecific antibodies for tumor directed immunotherapy of cancer . Dr. Furebring has more than 20 years of experience with protein and antibody optimization as well as generation of antibodies using phage display. Dr. Furebring completed her PhD in Immunotechnology from Lund University, Sweden.